Inhibition of murine bladder tumorigenesis by soy isofiavones via alterations in the cell cycle, apoptosis, and angiogenesis

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5231-5238

  Zhou, Jin Rong ^a   Mukherjee, Purna ^a   Gugger, Eric T ^b   Tanaka, Toshihide ^c   Blackburn, George L ^a   Clinton, Steven K ^d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ARCHER DANIELS MIDLAND COMPANY   (United States)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLAVONE DERIVATIVE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; DIET SUPPLEMENTATION; GROWTH CURVE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; DNA FRAGMENTATION; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GENISTEIN; HUMANS; ISOFLAVONES; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0032533508     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Messina, M. J., Persky, V., Setchell, K. D., and Barnes, S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer, 21: 113-131, 1994.
2. Kennedy, A. R. The evidence for soybean products as cancer preventive agents. J. Nutr., 125: 7335-7435, 1995.
3. Wang, H-J., and Murphy, P. A. Isoflavone composition of American and Japanese soybean in Iowa: effects of variety, crop year, and location. J. Agric. Food Chem., 42: 1674-1677, 1994.
4. Rao, A. V., and Sung, M-K. Saponins as anticarcinogens. J. Nutr., 125: 717s-724s, 1995.
5. Shamsuddin, A. M. Inositol phosphates have novel anticancer function. J. Nutr., 725: 725s-732s, 1995.
6. Barnes, S., and Peterson, T. G. Biochemical targets of the isoflavone genistein in tumor cell lines. Proc. Soc. Exp. Biol. Med., 208: 103-108, 1995.
7. Naik, H. R., Lehr, J. E., and Pienta, K. J. An in vitro and in vivo study of antitumor effects of genistein on hormone refractory prostate cancer. Anticancer Res., 14: 2617-2619, 1994.
8. Clinton, S. K., Destree, R., Anderson, D. B., Truex, C. R., Imrey, P. B., and Visek, W. J. 1,2-Dimethylhydrazine-induced colon cancer in rats fed beef or vegetable protein. Nutr. Rep. Int., 20: 335-342, 1979.
9. Rao, C. V., Wang, C-X., Simi, B., Lubet, R., Kelloff, G., Steele, V., and Reddy, B. S. Enhancement of experimental colon cancer by genistein. Cancer Res., 57: 3717-3722, 1997.
10. Hawrylewicz, E. J., Zapata, J. J., and Blair, W. H. Soy and experimental cancer: animal studies. J. Nutr., 125: 698s-708s, 1995.
11. Hawrylewicz, E. J., Huang, H. H., and Blair, W. H. Dietary soybean isolate and methionine supplementation affect mammary tumor progression in rats. J. Nutr., 127: 1693-1698, 1991.
12. Barnes, S., Grubbs, C., Setchell, K. D., and Carlson, J. Soybeans inhibit mammary tumors in models of breast cancer. Prog. Clin. Biol. Res., 347: 239-253, 1990.
13. Lamartiniere, C. A., Moore, J. B., Brown, N. M., Thompson, R., Hardin, M. J., and Barnes, S. Genistein suppresses mammary cancer in rats. Carcinogenesis (Lond.), 76: 2833-2840, 1995.
14. Murrill, W. B., Brown, N. M., Zhang, J-X., Manzolillo, P. A., Barnes, S., and Lamartiniere, C. A. Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis (Lond.), 77: 1451-1457, 1996.
15. Yanagihara, K., Ito, A., Toge, T., and Numoto, M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res., 53: 5815-5821, 1993.
16. Jing, Y., Nakaya, K., and Han, R. Differentiation of promyelocytic leukemia cells HL-60 induced by daidzein in vitro and in vivo. Anticancer Res., 13: 1049-1054, 1993.
17. Adlercreutz, C. H., Goldin, B. R., Gorbach, S. L., Hockerstedt, K. A., Watanabe, S., Hamalainen, E. K., Markkanen. M. H., Makela, T. H., Whala, K. T., Hase, T. A., and Fotsis, T. Soybean phytoestrogen intake and cancer risk. J. Nutr., 725: 757s-770s, 1995.
18. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., and Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem., 262: 5592-5595, 1987.
19. Naim, M., Gestetner, B., Bondi, A., and Birk, Y. Antioxidative and antihemolytic activities of soybean isoflavones. J. Agric. Food Chem., 24: 1174-1177, 1976.
20. Okura, A., Arakawa, H., Oka, H., Yoshinari, T., and Monden, Y. Effect of genistein on topoisomerase activity and on the growth of [VAL12]Ha-ras-transformed NIH 3T3 cells. Biochem. Biophys. Res. Commun., 757: 183-189, 1988.
21. Markovits, J., Linassier, C., Foss, P., Couprie, J., Pierre, J., Jacquemin, S., Saucier, J., LePecq, J, and Larsoen, A. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res., 49: 5111-5117, 1989.
22. Fotsis, T., Pepper, M., Adlercreutz, H., Fleischmann, G., Hase, T., Montesano, R., and Schweigerer, L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA, 90: 2690-2694, 1993.
23. Adlercreutz, H., Fotsis, T., Bannwart, C., Wahala, K., Brunow, G., and Hase, T. Isotope dilution gas chromatographic-mass spectrometric method for the determination of lignans and isoflavonoids in human urine, including identification of genistein. Clin. Chim. Acta, 199: 263-278, 1991.
24. Adlercreutz, H., Hockerstedt, K., Bannwart, C., Bloigu, S., Hamalainen, E., Fotsis, T., and Ollus, A. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG). J. Steroid Biochem., 27: 1135-1144, 1987.
25. Kelly, G. E., Nelson, C., Waring, M. A., Joannou, G. E., and Reeder, A. Y. Metabolites of dietary (soya) isoflavones in human urine. Clin. Chim. Acta, 223: 9-22, 1993.
26. Kirkman, L. M., Lampe, J. W., Campbell, D. R., Martini, M. C., and Slavin, J. L. Urinary lignan and isoflavonoid excretion in men and women consuming vegetable and soy diets. Nutr. Cancer, 24: 1-12, 1995.
27. Adlercreutz, H., Honjo, H., Higashi, A., Fotsis, T., Hamalainen, E., Hasegawa, T., and Okada, H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr., 54: 1093-1100, 1991.
28. Xu, X., Wang, H-J., Murphy, P. A., Cook, L., and Hendrich, S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J. Nutr., 124: 825-832, 1994.
29. Xu, X., Harris, K. S., Wang, H-J., Murphy, P. A., and Hendrich, S. Bioavailahility of soybean isoflavones depends upon gut microflora in women. J. Nutr., 125: 2307-2315, 1995.
30. Karr, S. C., Lampe, J. W., Hutchins, A. M., and Slavin, J. L. Urinary isoflavonoid excretion in humans is dose dependent at low to moderate levels of soy-protein consumption. Am. J. Clin. Nutr., 66: 46-51, 1997.
31. Hutchins, A. M., Slavin, J. L., and Lampe, J. W. Urinary isoflavonoid and lignan excretion after consumption of fermented and imfermented soy products. J. Am. Diet. Assoc., 95: 545-551, 1995.
32. Golbitz, P. Soyatech Surveys and Estimates. Soyatech, Inc., Bar Harbor, ME, 1992.
33. Adlercreutz, H., and Mazur, W. Phyto-oestrogens and Western diseases. Ann. Mod., 29: 95-120, 1997.
34. Wang, H., and Murphy, P. A. Isoflavone content in commercial soybean foods. J. Agric. Food Chem., 42: 1666-1673, 1994.
35. Roehm, N. W., Rodgers, G. H., Hatfield, S. M., and Glasebrook, A. L. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods, 142: 257-265, 1991.
36. American Institute of Nutrition. AIN second report of the ad hoc committee on standards for nutritional studies. J. Nutr., 110: 1726, 1980.
37. American Institute of Nutrition. AIN Report of the AIN ad hoc committee on standards for nutritional studies. J. Nutr., 107: 1340-1348, 1977.
38. Steel, R. G. D., and Torrie, J. H. Principles and Procedures of Statistics: A Biometrical Approach. Ed. 2. New York: McGraw-Hill Book Co., Inc., 1980.
39. Scheffé, H. A method for judging all contrasts in the analysis of variance. Biometrika, 40: 87-104, 1953.
40. King, R. A., Broadbent, J. L., and Head, R. J. Absorption and excretion of the soy isoflavone genistein in rats. J. Nutr., 126: 176-182, 1996.
41. Supko, J. G., and Malspeos, L. Plasma pharmacokinetics of genistein in mice. Int. J. Oncol., 7: 847-854, 1995.
42. McIntosh, G. H., Regester, G. O., Le Leu, R. K., Royle, P. J., and Smithers, G. W. Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J. Nutr., 125: 809-816, 1995.
43. Hsieh, C-Y., Chang, Y-C., Nair, M. G., and Helferich, W. G. Effects of dihydrogenistein, a metabolite of genistein, on human breast cancer (MCF-7 and MDA-231) cells in vitro. FASEB J., 11: A439, 1997.
44. Shiina, H., Igawa, M., Urakami, S., Honda, S., Shirakawa, H., and Ishibe, T. Immunohistochemical analysis of bc1-2 expression in transitional cell carcinoma of the bladder. J. Clin. Pathol., 49: 395-399, 1996.
45. Kyle, E., Bergan, R., and Neckers, L. Genistein inhibits prostate cancer cell growth by inducing apoptosis. Proc. Am. Assoc. Cancer Res., 37: 359, 1996.
46. McCabe, M. J., and Orrenius, S. Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem. Biophys. Res. Commun., 194: 944-950, 1993.
47. Azuma, Y., Onishi, Y., Sato, Y., and Kizaki, H. Induction of mouse thymocyte apoptosis by inhibitors of tyrosine kinases is associated with dephosphorylation of nuclear proteins. Cell. Immunol., 152: 271-278, 1993.
48. Bergamaschi, G., Rosti, V., Danova, M., Ponchio, L., Lucotti, C., and Cazzola, M. Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukemia (Baltimore). 7: 2012-2018, 1993.
49. Yarden, Y., and Ullrich, A. Growth factor receptors tyrosine kinases. Annu. Rev. Biochem., 57: 443-478, 1988.
50. Linassier, C., Pierre, M., LePecq, J-B., and Pierre, J. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol., 39: 187-193, 1990.
51. 2/M arrest in keratinocytes. Carcinogencsis (Lond.), 17: 2367-2375, 1996.
52. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., I: 27-31, 1995.
53. Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S-C., Skinner, D. G., and Nichols, P. W. Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J. Natl. Cancer Inst., 87: 1603-1612, 1995.
54. Philp, E. A., Stephenson, T. J., and Reed, M. W. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder. Br. J. Urol., 77: 352-357, 1996.
55. Nguyen, M., Watanabe, H., Budson, A., Richie, J. P., and Folkman, J. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients. J. Natl. Cancer Inst., 85: 241-242, 1993.
56. Schweigerer, L., Christeleit, K., Fleischmann, G., Adlercreutz, H., Wahala, K., Hase, T., Schwab, M., Ludwig, R., and Fotsis, T. Identification in human urine of a natural growth inhibitor for cells derived from solid pediatric tumors. Eur. J. Clin. Invest., 22: 260-264, 1992.
57. Hanahan, D., and Folkman, J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86: 353-364, 1996.